Continued expansion of Pattern’s IP portfolioSignificant progress in expanding industry-leading oncology pipeline REDMOND, Wash., June 12, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) announced at the Bio International Conference in San Diego that it is filing provisional patent applications with the United States Patent Office (USPTO) which covers 14 insilico discoveries in the form of potentially synergistic drug combinations for metastatic castrate resistant prostate cancer. Pattern expects these provisional patent applications to further strengthen its intellectual property....
The post Pattern Announces Filing of Provisional Patent Applications for Treatment of Metastatic Castration-Resistant Prostate Cancer appeared first on Vietnam Insider.